rs12910289
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001013619.4(HYKK):c.661+2160T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.315 in 152,150 control chromosomes in the GnomAD database, including 8,566 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.32 ( 8566 hom., cov: 32)
Consequence
HYKK
NM_001013619.4 intron
NM_001013619.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.733
Publications
11 publications found
Genes affected
HYKK (HGNC:34403): (hydroxylysine kinase) Enables hydroxylysine kinase activity. Predicted to be involved in lysine catabolic process. Predicted to be located in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2022]
HYKK Gene-Disease associations (from GenCC):
- inborn disorder of lysine and hydroxylysine metabolismInheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HYKK | ENST00000388988.9 | c.661+2160T>G | intron_variant | Intron 4 of 4 | 5 | NM_001013619.4 | ENSP00000373640.4 | |||
HYKK | ENST00000569878.5 | c.661+2160T>G | intron_variant | Intron 3 of 3 | 5 | ENSP00000455459.1 | ||||
HYKK | ENST00000408962.6 | c.661+2160T>G | intron_variant | Intron 4 of 4 | 5 | ENSP00000386197.2 | ||||
HYKK | ENST00000563233.2 | c.661+2160T>G | intron_variant | Intron 3 of 3 | 2 | ENSP00000454850.1 |
Frequencies
GnomAD3 genomes AF: 0.315 AC: 47925AN: 152032Hom.: 8569 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
47925
AN:
152032
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.315 AC: 47934AN: 152150Hom.: 8566 Cov.: 32 AF XY: 0.312 AC XY: 23220AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
47934
AN:
152150
Hom.:
Cov.:
32
AF XY:
AC XY:
23220
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
6741
AN:
41532
American (AMR)
AF:
AC:
3815
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1230
AN:
3472
East Asian (EAS)
AF:
AC:
856
AN:
5188
South Asian (SAS)
AF:
AC:
1667
AN:
4832
European-Finnish (FIN)
AF:
AC:
3895
AN:
10564
Middle Eastern (MID)
AF:
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28603
AN:
67968
Other (OTH)
AF:
AC:
673
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1631
3262
4892
6523
8154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
949
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.